Canadian life sciences Company
Rapid Dose Therapeutics Corp. (
CSE: DOSE,
Forum) reported its financial F-Q1 2020 results on Tuesday.
Highlights for the quarter ending May 31st, 2019 include:
- Revenue recognition from QuickStrip nutraceutical product sales
- QuickStrip distribution in Canada with TFB & Associates Ltd.
- MOU with Thrive Canabis to sell QuickStrip technology using cannabis distillate in Canada
For a full look at the review, click
here.
DOSE also made news earlier this month when it
finalized the last phase of its Managed Strip Services Agreement with
Flower One Holdings Inc. (CSE: FONE, OTCQB: FLOOF), who will manufacture, distribute and sell RDT's QuickStrip products in Nevada.
FULL DISCLOSURE: Rapid Dose Therapeutics Corp. and Flower One Holdings Inc. are clients of Stockhouse Publishing.